Contemporary use of nephron-sparing surgery for children with malignant renal tumors at freestanding children's hospitals.
Journal Article (Journal Article)
OBJECTIVE: It is widely accepted that, when feasible, nephron-sparing surgery (NSS) is preferable to radical nephrectomy (RN) for treatment of renal tumors in adults. However, RN is more frequently used in children. We sought to compare in-hospital outcomes after NSS and RN for malignant pediatric renal tumors. MATERIAL AND METHODS: The pediatric health information system (PHIS) combines data from more than 40 North American pediatric hospitals. We queried PHIS to identify children with malignant renal tumors who underwent surgery from 2003 to 2009. We examined whether outcomes (complication rates, cost, and length of stay) differed by procedure type. Multivariate regression models were used to adjust for confounding, and generalized estimating equations were used to adjust for hospital clustering. RESULTS: We identified 1235 children with renal tumors who underwent RN (91%) or NSS (9%). Patients undergoing RN and NSS had similar median comorbidity scores (P = .98), hospital lengths of stay (each 6.0 days, P = .54), in-hospital charges, ($25,700 vs $37,000, P = .11), and surgical complication rates (16.4 vs 20.5%, P = .24). These outcomes remained similar after adjusting for other patient and hospital factors. CONCLUSIONS: Most children with malignant renal tumors treated at children's hospitals undergo RN. RN and NSS use were not significantly different in terms of their length of hospital stay, in-hospital charges, and complication rates. Although oncological outcomes are lacking, these data suggest that NSS may be performed in selected children with malignant renal tumors without significantly increasing their hospital charges, length of stay, or surgical complication rates.
Full Text
Duke Authors
Cited Authors
- Routh, JC; Graham, DA; Estrada, CR; Nelson, CP
Published Date
- August 2011
Published In
Volume / Issue
- 78 / 2
Start / End Page
- 422 - 426
PubMed ID
- 21689846
Pubmed Central ID
- PMC3152612
Electronic International Standard Serial Number (EISSN)
- 1527-9995
Digital Object Identifier (DOI)
- 10.1016/j.urology.2010.12.048
Language
- eng
Conference Location
- United States